Getting your player ready...
LONDON — Drugmaker GlaxoSmithKline PLC said Friday that it has started testing its swine-flu vaccine in humans.
Glaxo said it plans to conduct 16 clinical trials in more than 9,000 people in Europe and North America. It expects to have early results in September from its first trial in Germany.
